PURE‑VISCHPMC Viscoelastic, ~9000 cps
The higher-viscosity HPMC in the Agaaz OVD line, built to create space and hold it. Reach for it when the chamber needs support, not just filling.
Chamber stability and
confident surgical flow.
PURE‑VISC maintains anterior chamber depth, protects intraocular structures, and supports confident surgical manipulation, with a higher-viscosity feel built for space and support.
Chamber Maintenance
Maintains stable anterior chamber depth throughout surgical manoeuvres for confident, controlled procedures.
Consistent ~9000 cps Hold
Formulated at a higher working viscosity so it creates and holds anterior chamber space where firmer mechanical support is needed.
Endothelial Protection
HPMC coats and protects the corneal endothelium during phacoemulsification and IOL implantation.
PFS Convenience
Prefilled syringe format eliminates preparation — ready for immediate, consistent delivery.
How HPMC viscoelastics
support cataract surgery.
HPMC-based OVDs are established anterior-segment surgical adjuncts that coat surfaces, maintain space, and protect tissue. PURE‑VISC’s higher viscosity is formulated to favour space maintenance and chamber support.
Chamber Injection
HPMC viscoelastic is injected into the anterior chamber, immediately creating a stable working space.
Surface Coating
Its higher-viscosity HPMC formulation is designed to hold its position and maintain a protective, stable layer through phacoemulsification.
Space Maintenance
Maintains anterior chamber depth throughout the procedure, preventing collapse and supporting confident manipulation.
Easy Removal
At close of surgery, the viscoelastic is aspirated. HPMC is designed for straightforward removal from the anterior chamber.
Key parameters at a glance.
What the published literature says about hpmc viscoelastics in cataract surgery
The clinical case for this product category does not rest on our own material. The studies below are independent, peer-reviewed and indexed in PubMed, and they cover hpmc viscoelastics in cataract surgery as a subject. Each entry links to its PubMed record so the primary source can be read in full.
- Systematic ReviewSafety profile of long-term intraocular ophthalmic viscoelastic devices: a systematic reviewKhalil R et al. (2026) · The British journal of ophthalmology · PMID 41558833
- Randomized Controlled TrialA clinical comparison between DisCoVisc and 2% hydroxypropylmethylcellulose in phacoemulsification: a fellow eye studyEspíndola RF et al. (2012) · Clinics (Sao Paulo, Brazil) · PMID 23018304
- Randomized Controlled TrialIntraocular pressure after phacoemulsification using hydroxypropyl methylcellulose and sodium hyaluronate as viscoelasticsWaseem M et al. (2007) · Journal of Ayub Medical College, Abbottabad : JAMC · PMID 17867479
Independent peer-reviewed publications indexed in PubMed. Listed as clinical background on the molecule and device class; they are not studies of Agaaz products and imply no endorsement.
Common questions about
HPMC viscoelastics.
Ready to bring PURE‑VISC
into your theatre?
~9000 cps HPMC in a ready-to-use prefilled syringe. Share your country and monthly volumes for pricing and documentation.